H. Jarva

H. Jarva, M. Lappalainen, S. Kurkela, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The rise and fall of Alpha and Beta variants of SARS-CoV2 in Finland in spring of 2021

S. Blomqvist, H. Jarva, P. Ellonen, 2021 .

Autoimmunity, Not a Developmental Defect, is the Cause for Subfertility of Autoimmune Regulator (Aire) Deficient Mice

S. Meri, H. Jarva, E. Kekäläinen, 2015, Scandinavian journal of immunology.

Capsule null locus meningococci: typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine.

S. Meri, H. Jarva, H. Claus, 2012, Vaccine.

Opc Expression, LPS Immunotype Switch and Pilin Conversion Contribute to Serum Resistance of Unencapsulated Meningococci

S. Meri, H. Jarva, H. Claus, 2012, PloS one.

Functional Recruitment of the Human Complement Inhibitor C4BP to Yersinia pseudotuberculosis Outer Membrane Protein Ail

A. Blom, S. Meri, V. Kirjavainen, 2012, The Journal of Immunology.

Outer Membrane Protein pseudotuberculosis Yersinia Complement Inhibitor C4BP to Functional Recruitment of the Human

Meri, A. Blom, V. Kirjavainen, 2012 .

Interaction of Pneumococcal Histidine Triad Proteins with Human Complement

S. Meri, H. Jarva, J. Poolman, 2010, Infection and Immunity.

Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection

H. Jarva, M. Lappalainen, S. Kurkela, 2021, Journal of Virological Methods.

an Analogous Fashion Bind the Complement Inhibitor Factor H in Related Immune Evasion Molecules That Pneumococcal Hic Proteins Are Structurally and b The Group B Streptococcal

S. Meri, P. Zipfel, H. Jarva, 2004 .

Identification of Glyceraldehyde‐3‐Phosphate and Alcohol Dehydrogenases as Autoantigens in Doberman Hepatitis

S. Meri, H. Jarva, T. Spillmann, 2017, Scandinavian journal of immunology.

Spontaneous Remission in Paroxysmal Nocturnal Hemoglobinuria—Return to Health or Transition Into Malignancy?

S. Meri, H. Jarva, Anna-Elina Armstrong, 2018, Front. Immunol..

Käyhty and Merja Väkeväinen Opsonophagocytosis than Serotype 6b Deposition and Less Sensitive to Serotype 19f Is More Resistant to C3 Capsular Streptococcus Pneumoniae

S. Meri, H. Jarva, H. Käyhty, 2008 .

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

H. Jarva, O. Vapalahti, M. Lappalainen, 2020, Journal of Clinical Virology.

The Salivary Scavenger and Agglutinin in Early Life: Diverse Roles in Amniotic Fluid and in the Infant Intestine

S. Meri, H. Jarva, J. M. Rodríguez, 2014, The Journal of Immunology.

and in the Infant Intestine Early Life: Diverse Roles in Amniotic Fluid The Salivary Scavenger and Agglutinin in

S. Meri, H. Jarva, W. Vos, 2014 .

Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection.

H. Jarva, A. Vaheri, S. Mäkelä, 2021, Vaccine.

SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility

H. Jarva, M. Lappalainen, L. Mannonen, 2020, Journal of Clinical Virology.

Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes

H. Jarva, T. Jokiranta, J. Vuopio‐Varkila, 2008 .

in the Regulation of Complement Activation Factor H: Interacting Domains and Function Binding of the Long Pentraxin PTX3 to

A. Mantovani, H. Jarva, T. Jokiranta, 2013 .

Microbial complement evasion and vaccine development.

S. Meri, H. Jarva, 2020, FEBS letters.

Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021

S. Blomqvist, H. Jarva, P. Ellonen, 2021, Emerging infectious diseases.

The phylodynamics of SARS-CoV-2 during 2020 in Finland

M. Suchard, P. Lemey, V. Kirjavainen, 2021, Communications Medicine.

Clinical characteristics and evaluation of the incidence of cryptococcosis in Finland 2004–2018

H. Jarva, T. Hautala, A. Jääskeläinen, 2021, Infectious diseases.

Human keratinocytes produce the complement inhibitor factor I: Synthesis is regulated by interferon-gamma.

S. Meri, H. Jarva, Z. Bhuiyan, 2007, Molecular immunology.

The Salivary Scavenger and Agglutinin (SALSA) in Healthy and Complicated Pregnancy

B. Huppertz, S. Meri, H. Jarva, 2016, PloS one.

Salmonella Outer Membrane Protein Rck of Human Complement Factor H Binds to

S. Meri, H. Jarva, Derek K. Ho, 2010 .

Comparison of Two Commercial Platforms and a Laboratory-Developed Test for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA

H. Jarva, M. Lappalainen, L. Mannonen, 2021, The Journal of Molecular Diagnostics.

Comparison of two commercial platforms and a laboratory developed test for detection of SARS-CoV-2 RNA

H. Jarva, M. Lappalainen, L. Mannonen, 2020, medRxiv.

Complement Regulatory Proteins

S. Meri, H. Jarva, 2001 .

Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome.

V. Salomaa, A. Havulinna, H. Jarva, 2017, Atherosclerosis.

Dysregulation of adaptive immune responses in complement C3‐deficient patients

T. Haahtela, S. Meri, H. Jarva, 2015, European journal of immunology.

Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021

S. Blomqvist, H. Jarva, A. Vaheri, 2022, Emerging infectious diseases.

Complement Regulation

S. Meri, H. Jarva, 1998, Vox sanguinis.

Interactions of soluble complement regulators with pathogenic bacteria

H. Jarva, 2004 .

Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

A. Järvinen, V. Kirjavainen, H. Jarva, 2020, medRxiv.

Complement Activation in Tear Fluid During Occupational Mold Challenge

T. Haahtela, S. Meri, H. Jarva, 2008, Ocular immunology and inflammation.

Immunoglobulins and complement factor C4 in adult rhinosinusitis

A. Järvinen, S. Meri, H. Jarva, 2006, Clinical and experimental immunology.

Significance of zinc in innate immune defense against Streptococcus pyogenes.

H. Jarva, 2014, The Journal of infectious diseases.

Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma.

S. Meri, H. Jarva, J. Bos, 2006, Molecular immunology.

Binding of the Long Pentraxin PTX3 to Factor H: Interacting Domains and Function in the Regulation of Complement Activation1

A. Mantovani, S. Meri, H. Jarva, 2008, The Journal of Immunology.

Complement Activation and Regulation in Preeclamptic Placenta

S. Meri, H. Jarva, M. Lokki, 2014, Front. Immunol..

Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery

S. Meri, H. Jarva, P. Nieminen, 2021, Frontiers in Immunology.

Complement Regulatory Proteins and Related Diseases

S. Meri, H. Jarva, 2013 .

Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis 1

A. Blom, S. Meri, H. Jarva, 2005, The Journal of Immunology.

Laboratory-based surveillance of COVID-19 in the Greater Helsinki area, Finland, February-June 2020

H. Jarva, M. Lappalainen, L. Mannonen, 2020, medRxiv.

Functional Recruitment of Human Complement Inhibitor C4b-Binding Protein to Outer Membrane Protein Rck of Salmonella

A. Blom, S. Meri, H. Jarva, 2011, PloS one.

Ascitic complement system in ovarian cancer

S. Meri, H. Jarva, O. Vintermyr, 2005, British Journal of Cancer.

A Novel Mutation W388X Underlying Properdin Deficiency in a Finnish Family

S. Meri, H. Jarva, I. Järvelä, 2012, Scandinavian journal of immunology.

Low incidence of severe bacterial infections in hospitalised patients with COVID-19: A population-based registry study

A. Meretoja, A. Järvinen, H. Jarva, 2022, Infectious diseases.

Interactions between Bordetella pertussis and the complement inhibitor factor H.

S. Meri, H. Jarva, T. Jokiranta, 2011, Molecular immunology.

Complement resistance mechanisms of streptococci.

S. Meri, H. Jarva, T. Jokiranta, 2003, Molecular immunology.

Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

S. Meri, H. Jarva, P. Kovanen, 2002, The Biochemical journal.

Complement activation in Puumala hantavirus infection correlates with disease severity

S. Meri, H. Jarva, A. Vaheri, 2012, Annals of medicine.

Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1

Don H. Anderson, Patrick T. Johnson, G. Hageman, 2007, The Journal of Immunology.

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells

S. Meri, P. Zipfel, H. Jarva, 2002, British Journal of Cancer.

Elevated levels of the complement regulator protein CD59 in severe acute pancreatitis

S. Meri, H. Jarva, H. Repo, 2008, Scandinavian journal of gastroenterology.

Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.

S. Meri, P. Zipfel, H. Jarva, 1999, Journal of immunology.

Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.

A. Blom, H. Jarva, S. Ram, 2005, Proceedings of the National Academy of Sciences of the United States of America.

The salivary scavenger and agglutinin binds MBL and regulates the lectin pathway of complement in solution and on surfaces

S. Thiel, S. Meri, H. Jarva, 2012, Front. Immun..

Factor H Binding as a Complement Evasion Mechanism for an Anaerobic Pathogen, Fusobacterium necrophorum1

S. Meri, H. Jarva, P. Mattila, 2008, The Journal of Immunology.

Streptococcus pneumoniae Evades Complement Attack and Opsonophagocytosis by Expressing the pspC Locus-Encoded Hic Protein That Binds to Short Consensus Repeats 8–11 of Factor H1

L. Björck, S. Meri, P. Zipfel, 2002, The Journal of Immunology.

Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant.

S. Meri, H. Jarva, M. Lokki, 2014, Antiviral research.

Functional Comparison of the Binding of Factor H Short Consensus Repeat 6 (SCR 6) to Factor H Binding Protein from Neisseria meningitidis and the Binding of Factor H SCR 18 to 20 to Neisseria gonorrhoeae Porin

H. Jarva, S. Ram, L. Lewis, 2009, Infection and Immunity.

Interaction with C4b-binding protein contributes to non-typeable Haemophilus influenzae serum resistance

A. Blom, K. Riesbeck, H. Jarva, 2007 .

Interaction with C4b-Binding Protein Contributes to Nontypeable Haemophilus influenzae Serum Resistance1

A. Blom, K. Riesbeck, H. Jarva, 2007, The Journal of Immunology.

Serum Resistance influenzae Haemophilus Contributes to Nontypeable Interaction with C4b-Binding Protein

A. Blom, K. Riesbeck, H. Jarva, 2007 .

Expanded CD4+ Effector/Memory T Cell Subset in APECED Produces Predominantly Interferon Gamma

P. Saavalainen, H. Jarva, E. Kekäläinen, 2016, Journal of Clinical Immunology.

Factor H − Repeats 8 Protein That Binds to Short Consensus Locus-Encoded Hic pspC by Expressing the Complement Attack and Opsonophagocytosis Evades Streptococcus pneumoniae

L. Björck, S. Meri, P. Zipfel, 2002 .

Characterization of Complement Factor H Binding to Yersinia enterocolitica Serotype O:3

S. Meri, H. Jarva, M. Biedzka-Sarek, 2008, Infection and Immunity.

Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 11

S. Meri, P. Zipfel, H. Jarva, 2000, The Journal of Immunology.

Human Complement Factor H Binds to Outer Membrane Protein Rck of Salmonella

S. Meri, H. Jarva, Derek K. Ho, 2010, The Journal of Immunology.

Microbial complement inhibitors as vaccines.

S. Meri, H. Jarva, M. Jördens, 2008, Vaccine.

Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes

H. Jarva, T. Jokiranta, J. Vuopio‐Varkila, 2008, Molecular microbiology.

Saliva‐based testing for diagnosis of SARS‐CoV‐2 infection: A meta‐analysis

H. Jarva, M. Lappalainen, S. Kurkela, 2020, Journal of medical virology.

epeat Domains 7 and 8 by an Interaction with Short Consensus R Complement Inhibitory Activity of Factor H C-Reactive Protein : Targeting the Regulation of Complement Activation by Zipfel and Seppo

S. Meri, P. Zipfel, H. Jarva, 1999 .

Molecular Characterization of the Interaction between Porins of Neisseria gonorrhoeae and C4b-Binding Protein1

A. Blom, H. Jarva, B. Villoutreix, 2007, The Journal of Immunology.

Factor H and Factor H-Like Protein 1 Killing by Expression and Utilization of Glioblastoma Cells to Complement-Mediated Exceptional Resistance of Human H 2 Zipfel

S. Meri, P. Zipfel, H. Jarva, 2000 .

Binding of complement regulators factor H and C4b binding protein to group A streptococcal strains isolated from tonsillar tissue and blood.

S. Meri, H. Jarva, J. Vuopio‐Varkila, 2008, Microbes and infection.

FASCIA Method in the Assessment of Lymphocyte Mitogen Responses in the Laboratory Diagnostics of Primary Immunodeficiencies

H. Jarva, S. Lehtimäki, K. Vettenranta, 2022, Journal of Clinical Immunology.

Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel

H. Jarva, L. Mannonen, J. Antikainen, 2023, Microbiology spectrum.

Human Complement Factor H Binds to Outer Membrane Protein Rck of Salmonella

S. Meri, H. Jarva, Derek K. Ho, 2010, The Journal of Immunology.

Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes

H. Jarva, T. Jokiranta, J. Vuopio‐Varkila, 2012 .

Identifying the inheritable component of human thymic T cell repertoire generation in monozygous twins

J. Saramäki, P. Saavalainen, S. Meri, 2019, European journal of immunology.

Streptococcus pneumoniae Capsular Serotype 19F Is More Resistant to C3 Deposition and Less Sensitive to Opsonophagocytosis than Serotype 6B

S. Meri, H. Jarva, H. Käyhty, 2008, Infection and Immunity.

Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes

H. Jarva, T. Jokiranta, J. Vuopio‐Varkila, 2008, Molecular microbiology.

Characterization of Complement Factor H Binding to Yersinia enterocolitica Serotype O:3

S. Meri, H. Jarva, M. Skurnik, 2008, Infection and Immunity.